Skip to main content
CureVac N.V. logo

CureVac N.V. — Investor Relations & Filings

Ticker · CVAC US Manufacturing
Filings indexed 250 across all filing types
Latest filing 2021-02-03 Foreign Filer Report
Country US United States of America
Listing US CVAC

About CureVac N.V.

https://www.curevac.com/

CureVac N.V. is a global biopharmaceutical company that develops transformative medicines based on messenger ribonucleic acid (mRNA). With over two decades of experience, the company leverages its proprietary mRNA technology platform to enable the human body to produce its own therapeutic proteins to fight a wide range of diseases. CureVac's clinical development pipeline is focused on creating prophylactic vaccines for infectious diseases, as well as therapies in oncology and for rare diseases. The company collaborates with partners to advance its portfolio of mRNA-based candidates.

Recent filings

Filing Released Lang Actions
FORM 6-K
Foreign Filer Report
2021-02-03 English
FORM 6-K
Foreign Filer Report
2021-02-02 English
SC 13D/A
Major Shareholding Notification
2021-02-01 English
FORM 6-K
Foreign Filer Report
2021-02-01 English
424B4
Prospectus
2021-01-29 English
FORM 6-K
Foreign Filer Report
2021-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.